ABSTRACT
INTRODUCTION
Here, taking advantage of yeast genetics, we found that AICAR treatment is 119 synthetic lethal with specific histone-modification defects including bre1 deletion, loss 120 of H2B ubiquitination, COMPASS-subunit deletions or loss of H3K4 methylation. We 121 showed that AICAR affects G1 progression, impacts on Cln1 protein level and on
122
Cln3 localization and thereby impacts on CLN1 and CLN2 transcription. In parallel we 123 found that bre1 deletion, H2B ubiquitination loss, set1 deletion or loss of H3K4 124 methylation also led to G1 cyclins expression default. Thus, by affecting 125 simultaneously the three G1 cyclins, AICAR and bre1/H2B/set1/H3K4 deletions are 126 synthetic lethal. Remarkably, these chemo-genetic synthetic interactions were 127 conserved in human cells.
128

MATERIAL AND METHODS
129
Media, strains and plasmids
130
Identification of the bre1-1 mutation resulting in AICAR sensitivity in the Y7322 142 mutant was done as previously described (Ceschin et al. 2014 Northern Blots were performed as described in (Denis et al. 1998 ) . Oligonucleotides 
183
Western blot 184 For protein extraction from yeast cells, strains were grown in exponential phase at
185
30°C during 24 hours in liquid SD casa WAU medium. Cells were shifted to 37°C for 186 30 minutes and then either supplemented or not with 1 mM AICAR during 2 hours.
187
For mammalian cells, after siRNA treatment, 0.5 mM AICAR was added for 72 hours.
188
Protein extracts, separated by SDS-PAGE and transferred onto PVDF membranes,
189
were probed with antibodies against c-Myc 9E10 (purchased from Thermo Scientific
190
(1/500)), Rnf40 (purchased from Sigma Aldrich (1/2,000)), Ash2l (purchased from
191
Millipore 7E1 (1/2,000)), Mll2 (purchased from Sigma Aldrich (1/2000)),
192
CCND1/CCNE1 (both purchased from Cell Signaling (1/2,000)), p53 (purchased from
193
Cell Signaling (1/2,000)) and p21 (purchased from Cell Signaling (1/500)). shown on Figure S1A ). The control strain was plated, mutagenized with UV light for 
251
One of these mutants ( Figure 1A ) was further studied. It should be noticed that 252 the AICAR-sensitivity of this mutant was strongly enhanced at high temperature
253
( Figure 1A ) and thus most of the experiments presented herein were performed at 254 37°C. Importantly, this mutant showed no major difference in its metabolic profile Figure S1B ). This mutation 263 was recessive ( Figure S1C ) and was complemented by the wild-type gene carried on 264 a centromeric plasmid ( Figure S1D ). Finally, we could show that a complete deletion 265 of the BRE1 coding region led to a similar sensitivity to AICAR ( Figure S1E ).
266
Together these results establish that the phenotype is due to a BRE1 loss of function. 45.55% ± 3.88 (set1) ( Figure 3A) . Altogether, these results point to a specific defect 322 in G1 progression associated with AICAR treatment and we thus investigated the 323 AICAR contribution to this effect.
324
In G1, at the beginning of the cell cycle, Whi5, the yeast equivalent of Whi5 phosphorylation and its exclusion from the nucleus (Dirick and Nasmyth 1991).
332
To elucidate how AICAR impacts on G1 progression, we evaluated the effects of Figure 3D ). Of note, Cdc28/Cdk1 protein levels were not 339 altered by AICAR treatment ( Figure 3D ).
340
The low expression of Cln1 upon AICAR treatment suggested that this protein deletion caused a decrease of CLN2, but also of CLN1 expression ( Figure 5A ). By 387 contrast, bre1 had no effect on CLN3 expression ( Figure 5A ). Moreover, we now 388 established that these effects on G1 cyclin transcription were also found in the H2B showed almost no growth defect. The rad6 cln1 strain showed a growth defect 433 although less pronounced than the one observed for rad6 cln3 ( Figure S3C ).
434
We next tested the effect of G1-cyclin deletions on AICAR sensitivity. Cln1 435 deletion alone had no impact on AICAR sensitivity ( Figure S3D Figure 8G ).
502
In the three knocked-down conditions, AICAR treatment caused a slight increase deregulation in cell cycle progression, it is of major importance to get insights into the 590 interplay between chromatin modifications and cell-cycle control.
591
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618
Plates were imaged after 3 days at 37°C. were transformed with p5488, p5489 or p5496 and then treated as described for 671 beta-galactosidase analysis. *** p < 0.001 ** p < 0.01 * p < 0.05; two way ANOVA. The bre1-1 mutation is genetically linked to AICAR sensitivity. Cells were grown overnight on SDcasaWAU medium, serially diluted, and spotted on the same medium containing (2 mM) or not AICAR. The strains, Y7322, Y6986 and four representative derived spores are shown (BRE1 or bre1-1 status was determined by Sanger sequencing). Plates were imaged after 1 day at 37°C. (C) The bre1-1 mutation is recessive. Diploid strains (ade16/ade16 ade17/ade17 ade8/ade8 his1/his1) carrying the indicated combinations of BRE1 alleles either mutated (bre1-1) or not (BRE1) were spotted on SDcasaWAU medium supplemented or not with AICAR (2 mM). Plates were imaged after 2 days at 37°C. (D) AICAR sensitivity of the bre1-1 allele is complemented by the wild-type BRE1 gene. The strain Y7322 was transformed with p344 or p4864. Transformants were spotted on SDcasaWA medium. Plates were imaged after 2 days at 37 °C. (E) Deletion of BRE1 leads to AICAR sensitivity. The strains Y2950) and Y9516 were spotted on SDcasaWAU medium supplemented or not with AICAR (2 mM). Plates were imaged after 3 days at 37°C. (F) bre1 synthetic lethality with ZMP is independent of its external or internal origin. Strains were spotted on SDcasaWAU medium for 2 days at 37°C before imaging: Y2948, Y8910, Y9100, Y1367, Y9143, Y9921 and Y10058. (G) PHO13-1 expression suppresses the growth defect of the bre1 ade16 ade17 strain. The strains Y2948 and Y9100 were transformed with p798 or p3438. Transformants were spotted on SDcasaWA medium for 2 days. The control strain Y2950 was transformed with multicopy plasmids (O.E: overexpression) p339, p5323, p5325 or p4742. Transformants were serial diluted on SDcasaWA supplemented or not with AICAR (10 mM) and plates were imaged after 3 days at 37°C.
Figure S3: cln3 deletion is synthetic sick with set1, bre1 or rad6 deletions.
(A) set1 deletion is synthetic sick with cln3 deletion and not cln1 or cln2 deletions. Several spores derived from individual tetrads were serial diluted and spotted on YPDA medium during 2 days at 25°C. (B) bre1 is synthetic sick with cln3 deletion and not cln1 deletion. The following strains were diluted and spotted on YPDA at 25°C during 2 days: Y9322, Y8910, Y9045, Y10830, Y1351 and Y10694. (C) rad6 is highly synthetic sick with cln3 deletion and less with cln1 deletion. The following strains were diluted and spotted on YPDA at 25°C during 2 days: Y9322, Y1367, Y8693, Y10832, Y1351 and Y10834.
